Trial
NCT00884039
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Cornea Research Foundation of America
Collaborators
—
Condition
Transplant
Intervention
anecortave acetate
Why stopped
Preliminary data analysis showed insufficient efficacy to justify continuation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-14